News alert: Johnson & Johnson’s one-shot COVID-19 vaccine is 66% effective in preventing moderate to severe illness, company says

Johnson & Johnson's vaccine protects against COVID-19 but not as strong as others already available, data released Friday from the company shows. Trials in the U.S. and seven other countries showed 66% effectiveness in its vaccine in preventing moderate to severe illness, the company said. It was 85% protective against the most serious symptoms. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
usatoday.com

News Alert
 
Friday, January 29
Johnson & Johnson's one-shot COVID-19 vaccine is 66% effective in preventing moderate to severe illness, company says
Johnson & Johnson's vaccine protects against COVID-19 but not as strong as others already available, data released Friday from the company shows. Trials in the U.S. and seven other countries showed 66% effectiveness in its vaccine in preventing moderate to severe illness, the company said. It was 85% protective against the most serious symptoms.
Read More
 
FOLLOW US
FB TW IG

Problem viewing email? View in browser

Unsubscribe Manage Newsletters Terms of Service Privacy Policy/Your California Privacy Rights Privacy Notice Do Not Sell My Info/Cookie Policy Feedback

Comments

Popular Posts

January 3nd Nоte (Оpen Up)

Reduced Payment!.

We have Your e-Wallet ready. Claim in 3hrs

Your order requires immediate confirmation.

Beneficiary countersignature modification

You’re four weeks away from more followers 📱

The State Department requires proof that you are the owner.

Commissions Successfully

Fwd: Claim "Climate law & governance" for your profile